Blueprint Medicines Corp (BPMC) Stock: Deerfield Management Reports New 4.51% Stake

Page 9 of 12

Page 9 of 12 – SEC Filing
CUSIP No.
09627Y109
13G
Page 10 of 10 Pages
SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
DEERFIELD MGMT, L.P.
By: J.E. Flynn Capital, LLC, General Partner
By: /s/ Jonathan Isler
      Jonathan Isler, Attorney-In-Fact
DEERFIELD MANAGEMENT COMPANY, L.P.
By:  Flynn Management LLC, General Partner
By: /s/ Jonathan Isler
      Jonathan Isler, Attorney-In-Fact
DEERFIELD PARTNERS, L.P.
By: Deerfield Mgmt, L.P., General Partner
By: J.E. Flynn Capital, LLC, General Partner
By: /s/ Jonathan Isler
      Jonathan Isler, Attorney-In-Fact
DEERFIELD INTERNATIONAL MASTER FUND, L.P.
By: Deerfield Mgmt, L.P., General Partner
By: J.E. Flynn Capital, LLC, General Partner
By: /s/ Jonathan Isler
      Jonathan Isler, Attorney-In-Fact
JAMES E. FLYNN
 
/s/ Jonathan Isler
Jonathan Isler, Attorney-In-Fact
Date:  October 25, 2016
 

Follow Blueprint Medicines Corp (NASDAQ:BPMC)

Page 9 of 12